AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Knowing what not to do as a new investor can save you time and money. Avoid common mistakes to build a successful investment portfolio.
28,036 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Oil prices posted their largest quarterly price decline in six years during Q2 2026, as easing supply constraints and...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...
Netflix is tightening access to viewing data as it trims public reporting on audience insights, prompting a cautious ...
A small, less-known U.S. LNG exporter is emerging as a potential winner as Europe faces a gas crunch amid Middle East...
In March 2026, XRP and Ethereum trade near multi-month lows. This piece analyzes how far a $1,000 bet could grow in e...
ECL, EMN, and BCC report mixed quarters as 2026 guidance and cost actions set the tone for a volatile chemicals secto...
The Department of Justice confirmed an active antitrust inquiry into the U.S. beef industry, targeting major meatpack...
The bitcoin outflows just 3-month window intensified Friday, with a $635 million pull on May 13 led by BlackRock’s IB...
Qualcomm surges 12%, Skyworks rallies 9%, and Qorvo climbs 7% as a narrowing set of mobile-chip winners outpaces broa...
Canada is urging a 16-year renewal of the USMCA with the United States and Mexico, signaling a push for long-term cer...
With the Fed set to act this month, a dirt-cheap stock looks attractive amid crosscurrents in the market. Here’s why ...